HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mattea Reinisch Selected Research

DNA (Deoxyribonucleic Acid)

1/2021Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mattea Reinisch Research Topics

Disease

39Breast Neoplasms (Breast Cancer)
04/2024 - 12/2012
15Neoplasms (Cancer)
12/2023 - 02/2013
6Pathologic Complete Response
11/2023 - 12/2021
3Neoplasm Metastasis (Metastasis)
01/2021 - 10/2019
2Male Breast Neoplasms (Male Breast Cancer)
01/2020 - 01/2019
1Mouth Neoplasms (Oral Cancer)
12/2023
1Disease Progression
12/2023
1Triple Negative Breast Neoplasms
01/2023
1Alopecia (Baldness)
10/2021
1Infections
10/2021
1Nausea
10/2021
1Vomiting
10/2021
1Fatigue
08/2021
1Sleep Initiation and Maintenance Disorders (Insomnia)
08/2021
1Hypesthesia (Numbness)
08/2020
1Ovarian Neoplasms (Ovarian Cancer)
08/2020
1Dyspnea (Shortness of Breath)
08/2020
1Noninfiltrating Intraductal Carcinoma (DCIS)
10/2019
1Thromboembolism
01/2019
1Congenital Abnormalities (Deformity)
10/2018
1Carcinoma (Carcinomatosis)
04/2017
1Neutropenia
03/2013
1Febrile Neutropenia
03/2013

Drug/Important Bio-Agent (IBA)

5Hormones (Hormone)IBA
12/2023 - 04/2021
4Phenobarbital (Luminal)FDA Link
11/2023 - 10/2019
4taxaneIBA
06/2023 - 04/2017
3ErbB Receptors (EGF Receptor)IBA
12/2023 - 10/2021
3AnthracyclinesIBA
10/2019 - 04/2017
2Epidermal Growth Factor (EGF)IBA
12/2023 - 12/2023
2palbociclibIBA
12/2023 - 12/2023
2130-nm albumin-bound paclitaxelIBA
11/2023 - 01/2022
2DenosumabFDA Link
11/2023 - 01/2022
2Trastuzumab (Herceptin)FDA Link
12/2022 - 02/2013
2TamoxifenFDA LinkGeneric
01/2020 - 01/2019
2Taxoids (Taxanes)IBA
01/2015 - 03/2013
1Letrozole (Femara)FDA LinkGeneric
12/2023
1ribociclibIBA
12/2023
1Anastrozole (Arimidex)FDA LinkGeneric
12/2023
1Cyclin-Dependent Kinase 4IBA
12/2023
1NivolumabIBA
12/2023
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
11/2023
1Biomarkers (Surrogate Marker)IBA
11/2023
1sacituzumab govitecanIBA
01/2023
1Estrogen ReceptorsIBA
03/2022
1Estradiol (Delestrogen)FDA LinkGeneric
04/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1olaparibIBA
01/2020
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2020
1Poly Adenosine Diphosphate RiboseIBA
01/2020
1Colloids (Colloid)IBA
10/2019
1Indicators and Reagents (Reagents)IBA
04/2017
1Bevacizumab (Avastin)FDA Link
01/2015
1Capecitabine (Xeloda)FDA Link
01/2015
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
03/2013
1Messenger RNA (mRNA)IBA
02/2013

Therapy/Procedure

18Neoadjuvant Therapy
04/2024 - 03/2013
11Drug Therapy (Chemotherapy)
06/2023 - 12/2012
6Therapeutics
12/2023 - 08/2020
3Lymph Node Excision (Lymph Node Dissection)
04/2024 - 10/2019
3Adjuvant Chemotherapy
06/2023 - 12/2012
2Mammaplasty (Breast Reconstruction)
01/2023 - 10/2018
2Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 01/2015
1Subcutaneous Injections
12/2022
1Radiotherapy
12/2021
1Palliative Care (Palliative Therapy)
10/2021
1Ear Acupuncture
08/2021
1Subcutaneous Mastectomy
10/2018
1Surgical Instruments (Clip)
04/2018